Help appealing denials for this non-hormonal treatment for menopause hot flashes.

Appeal Your Lynkuet Denial

Get access to this first dual-target non-hormonal treatment for menopause hot flashes.

Understanding Your Lynkuet (elinzanetant) Denial

Lynkuet (elinzanetant) is the first and only dual neurokinin receptor antagonist approved for moderate to severe hot flashes due to menopause. As a non-hormonal option, it's particularly important for women who cannot or prefer not to take hormone therapy. Insurance denials often impose step therapy through hormone therapy first.

Common Reasons for Denial

! Must try hormone therapy first
! Prior authorization required
! Not medically necessary
! Hot flash severity not documented
! Preferred alternative required
! New drug with limited coverage policies

How We Help

We help you document your hot flash severity, reasons for avoiding hormone therapy (breast cancer history, cardiovascular risk, personal preference), and impact on quality of life.

Start your Lynkuet appeal — it takes about 3 minutes.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ Elinzanetant is a dual NK1/NK3 receptor antagonist that reduces hot flashes by targeting the neurokinin pathway in the brain's thermoregulatory center.

✓ Clinical trials demonstrated significant reduction in hot flash frequency and severity compared to placebo.

✓ Non-hormonal options are essential for women with contraindications to hormone therapy, including breast cancer survivors.

✓ Menopause symptoms significantly impact quality of life, sleep, and work productivity for millions of women.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

Lynkuet Access Savings & Support (LASS)

Commercially insured women may pay as little as $25 per month through the LASS program with Blink Rx. Bayer Patient Assistance Foundation available for eligible uninsured patients. Call 1-866-228-7723.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

North American Menopause Society

Leading nonprofit organization for menopause health information and advocacy.

The Menopause Society

Professional organization promoting menopause health through education and advocacy.

Frequently Asked Questions

Many women cannot take hormone therapy due to breast cancer history, blood clot risk, cardiovascular disease, or other medical conditions. Others prefer to avoid hormones. Your appeal should document your specific reasons.

Track the number and severity of hot flashes per day, night sweats, sleep disruption, and impact on work and daily activities. Your healthcare provider can also document this in clinical notes.

Ready to Fight Your Lynkuet (elinzanetant) Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including Bayer AG. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.